LENZ Therapeutics, Inc.
LENZNASDAQHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $98.67M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $3.12$36.43
- Volume (live)
- -
- Avg. volume (3M)
- 758.40K
LENZ Therapeutics (LENZ) Stock Price & Financial Analysis
LENZ Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.10 - $3.20 |
|---|---|
| 52-Week High | $36.43 |
| 52-Week Low | $3.12 |
| Open | $3.16 |
| Volume (last close) | 389.14K |
| Average Volume (3M) | 758.40K |
| Revenue (TTM) | 21.48M |
|---|---|
| Net Income (TTM) | -126.00M |
| Free Cash Flow (TTM) | -114.42M |
| EPS (TTM) | −$4.12 |
| Profit Margin | -586.74% |
| Operating Margin | -631.70% |
| Return on Equity (ROE) | -57.47% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Mar 22, 2024 |
| Market Cap | 98.67M |
|---|---|
| Shares Outstanding | 31.37M |
| Price to Sales (P/S) | 4.59 |
| Price to Book (P/B) | 0.45 |
| EV/EBITDA | -0.59 |
| 50-Day MA | $4.33 |
|---|---|
| 200-Day MA | $8.54 |
| 1-Year Change | −89.64% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
LENZ Therapeutics at a Glance
As of the Oct 26, 2026 close, LENZ Therapeutics (LENZ) has a market capitalization of $98.67M. The stock trades at 4.6× sales. Over the trailing twelve months it lost $126.00M on revenue of $21.48M and burned $114.42M of free cash flow. Revenue grew 329.5% year over year.
As of its latest reported balance sheet, it holds $24.21M in cash and securities against $122.00K of debt, a net cash position of $24.09M.
LENZ Therapeutics does not currently pay a dividend.
The share price is down 89.6% over the past year. At $3.15 (the Oct 26, 2026 close) it sits near the bottom of its 52-week range of $3.12 to $36.43, below its 200-day moving average of $8.54.
Based on 6 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $22.00, 599.5% above the Oct 26, 2026 close.
Frequently Asked Questions About LENZ Therapeutics
What is the current stock price for LENZ?
As of the Oct 26, 2026 close, LENZ stock trades at $3.15. The 52-week range is $3.12–$36.43, with a day range of $3.10–$3.19.
What is the P/E ratio for LENZ?
The P/E ratio (Price-to-Earnings) for LENZ is shown in the Key Statistics section. This valuation metric helps compare LENZ Therapeutics, Inc. to industry peers.
Does LENZ pay dividends?
LENZ Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LENZ?
Based on ratings from 6 professional analysts over the last 90 days, the consensus for LENZ is Buy. The average 12-month price target is $22.00, a 599.5% upside from the Oct 26, 2026 close of $3.15.
What is the market cap of LENZ?
As of the Oct 26, 2026 close, LENZ Therapeutics's market capitalization is $98.7M, classifying it as a micro-cap company. LENZ Therapeutics operates in the Healthcare sector within the Biotechnology industry.